Effects of COVID-19 on Respiratory System

被引:0
|
作者
Karahalil, Bensu [1 ]
Deniz, Muhammed Ercan [1 ]
Iyigundogdu, Irem [1 ]
Tumer, Miray [1 ]
机构
[1] Gazi Univ, Fac Pharm, Dept Pharmaceut Toxicol, Ankara, Turkey
来源
GAZI MEDICAL JOURNAL | 2020年 / 31卷 / 3A期
关键词
COVID-19; viral entry; ACE2; receptor; respiratory system; SARS-CoV; ARDS; CORONAVIRUS;
D O I
10.12996/gmj.2020.124
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Coronavirus disease 2019 (COVID-19) was caused by a novel type of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It was originated in Wuhan, China in December 2019. It spreads rapidly all over the world since respiratory virus infection can occur through many easy ways (e.g. contact, droplet spray, aerosol) and besides, asymptomatic people also have contagiousness. So far, there have been 23,491,520 confirmed cases of COVID-19, including 809,970 deaths, reported to World Health Organization (WHO), which declared it as a significant threat to global health. Fever, fatigue, and dry cough are the commonly observed symptoms in the patients. In COVID-19, the main affected system is respiratory system and some cases demonstrate a rapid progression to acute respiratory distress syndrome (ARDS), while other organs are less involved. Angiotensin-converting enzyme 2 receptor-virus association is essential and responsible for the development of the disease. SARS-CoV-2 causes deaths through its severe effects on the respiratory system.
引用
收藏
页码:528 / 531
页数:4
相关论文
共 50 条
  • [1] Effects of COVID-19 on the Nervous System
    Iadecola, Costantino
    Anrather, Josef
    Kamel, Hooman
    CELL, 2020, 183 (01) : 16 - +
  • [2] The effects of COVID-19 on the vestibular system
    Zaubitzer, Lena
    Ludwig, Sonja
    Berkemann, Michelle
    Walter, Beatrice
    Jungbauer, Frederic
    Held, Valentin
    Hegemann, Stefan C. A.
    Rotter, Nicole
    Schell, Angela
    FRONTIERS IN NEUROLOGY, 2023, 14
  • [3] Respiratory and cardiovascular effects of COVID-19 infection and their management
    Kapoor, Mukul Chandra
    JOURNAL OF ANAESTHESIOLOGY CLINICAL PHARMACOLOGY, 2020, 36 : S21 - S28
  • [4] Specific Respiratory System Compliance in COVID-19 and Non-COVID-19 Acute Respiratory Distress Syndrome
    Pozzi, Tommaso
    Collino, Francesca
    Brusatori, Serena
    Romitti, Federica
    Busana, Mattia
    Moerer, Onnen
    Camporota, Luigi
    Chiumello, Davide
    Coppola, Silvia
    Gattinoni, Luciano
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 208 (03) : 328 - 330
  • [5] Respiratory Physiotherapy and COVID-19
    Abreus Mora, Jorge Luis
    Gonzalez Curbelo, Vivian Barbara
    FINLAY, 2021, 11 (03): : 323 - 326
  • [6] The Role of the Acetylcholine System in Common Respiratory Diseases and COVID-19
    Li, Dehu
    Wu, Jianghua
    Xiong, Xianzhi
    MOLECULES, 2023, 28 (03):
  • [7] Nanocarriers in the Delivery of Hydroxychloroquine to the Respiratory System: An Alternative to COVID-19
    Cavalcanti, Iago Dillion Lima
    Medeiros, Sandrelli Meridiana de Fatima Ramos dos Santos
    Macedo, Daniel Charles dos Santos
    Cavalcanti, Isabella Macario Ferro
    Nogueira, Mariane Cajuba de Britto Lira
    CURRENT DRUG DELIVERY, 2021, 18 (05) : 583 - 595
  • [8] Considering the long-term respiratory effects of Covid-19
    Hayes, James P.
    OCCUPATIONAL MEDICINE-OXFORD, 2021, 71 (08): : 325 - 327
  • [9] Effects of early mobilization on patients with COVID-19 with respiratory failure
    Fukuta, Yoshitatsu
    Arizono, Shinichi
    Yoshida, Tomoya
    Mizuno, Yuji
    Tawada, Masahiro
    Magata, Junichi
    Uruno, Takaki
    Watanabe, Kazuki
    Ozaki, Akihiko
    Imaizumi, Yoshinori
    RESPIROLOGY, 2023, 28 (02) : 194 - 195
  • [10] The effects of the COVID-19 pandemic on community respiratory virus activity
    Chow, Eric J.
    Uyeki, Timothy M.
    Chu, Helen Y.
    NATURE REVIEWS MICROBIOLOGY, 2023, 21 (03) : 195 - 210